Aarti Pharmalabs LimitedShare price targets & analyst calls
₹858.8-9.30 (-1.07%)
As of 4 Sept 2026
Analysts lean BUY·all 2 long-term calls are BUY·consensus 1Y target ₹967.5 (12.7% above CMP)
₹967.5
12.7% above CMP
₹965 – ₹970
2 active 1Y targets
3 open
3 BUY · 0 SELL (all horizons)
N/A
1 of 10 closed calls needed
Watch AARTIPHARM for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips (4) · loading…
BUYAARTIPHARMAarti PharmalabsHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 5 mo left
AI4+·1−+14.5% P&L+12.4% upside left
₹858.8
CMP
Entry*
₹749.85
Target
₹965
ISICICI Securities· via Institutional / Brokerage Research29w ago
BUYAARTIPHARMAarti PharmalabsHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 2 mo left
AI4+·1−+20.4% P&L+12.9% upside left
₹858.8
CMP
Entry*
₹713.2
Target
₹970
ISICICI Securities· via Institutional / Brokerage Research42w ago
BUYAARTIPHARMAarti PharmalabsHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance) · 9d left
AI2+·1−-1.3% P&L+4.8% upside left
₹858.8
CMP
SL
₹845
Entry*
₹870.2
Target
₹900
NJNilesh Jain, Centrum Broking· via Zee Business (Live)5d ago
BUYAARTIPHARMAarti PharmalabsHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI3+·1−+3.28% realised0.0% upside left
SL
₹800
Entry*
₹823
Target
₹850
hit 11 Aug 2026, 9:15 am
NJNilesh Jain, Centrum Broking· via NDTV Profit (Live)3w ago